Chromosomal translocations and/or their molecular equivalents involving the BCL6 gene on 3q27 band have been suggested to be involved in the development of nonHodgkin's lymphoma of B-cell type (B-NHL). The rearrangement of BCL6 sometimes coexists with other translocations speci®c to B-NHL. Here, we report a novel B-cell lymphoma cell line, YM, established from a patient with diuse large cell lymphoma. The YM cells expressed B-cell-associated antigens in addition to md/k monoclonal immunoglobulin. Southern blot analysis of DNA from YM cells demonstrated rearrangement of the BCL2 gene within the 5'¯anking region (5'-BCL2). Polymerase chain reaction (PCR) using primer pairs for the BCL2 exons 1 and 2, and for the constant region of the immunoglobulin k light chain gene (IGk) revealed PCR products encompassing the 5'-BCL2/IGk fusion, indicating that the YM cells had a t(2;18)(p11;q21) translocation. The BCL6 gene was rearranged at a point within the ®rst intron, and cloning of the rearranged BCL6 revealed unidenti®ed sequences juxtaposed to the 5' side of the gene. The isolated clones were mapped to 16p11.2 by high resolution¯uorescence in situ chromosomal hybridization. Thus, the YM cells carried a 3q27 translocation involving 16p11.2 as a partner. Chromosome painting of metaphase spreads con®rmed that the YM cells had both t(2;18) and t(3;16). Northern blot analysis using a fragment immediately adjacent to the breakpoint on 16p11.2 revealed transcriptional activity within this locus. The YM cells expressed abundant transcripts with aberrant sizes from BCL2 and BCL6, indicating deregulated overexpression of the two genes resulting from the t(2;18) and t(3;16). The YM cell line will therefore be useful to study whether BCL2 and BCL6 genes collaborate in the pathogenesis of B-NHL.
Introduction
Non-Hodgkin's lymphoma of B-cell type (B-NHL) is characterized by chromosomal translocations and/or their molecular equivalents that are closely correlated with speci®c histological phenotypes (Rabbitts, 1994) . The BCL6 gene was identi®ed in the vicinity of the breakpoints on 3q27 involved in t(3;14)(q27;q32) (Ye et al., 1993b) and t(3;22)(q27;q11) (Miki et al., 1994a) . The gene encodes a member of the zinc-®nger family of transcriptional factors (Kerckaert et al., 1993; Ye et al., 1993a; Miki et al., 1994b) . Initial studies suggested that rearrangement of the BCL6 gene is involved in the diuse large cell subtype of B-NHL (Ye et al., 1993a) . However, in later larger series, this genetic lesion was found in a signi®cant proportion of follicular lymphomas (Otsuki et al., 1995; Muramatsu et al., 1996) . Nevertheless, 3q27 translocation and/or BCL6 rearrangement are the most common genetic abnormalities in B-NHL. 3q27 translocations, unlike other translocations studied previously, are unique in that they can involve not only immunoglobulin (IG) gene loci but also other as yet uncharacterized chromosomal loci as partners (Ye et al., 1993a; Bastard et al., 1994; Kluin, 1994; Wlodarska et al., 1995) . To date, more than 20 chromosomal sites have been reported to be translocation partners of 3q27 . Some of these translocations have been described by two or more independent laboratories indicating that they are recurrent chromosomal translocations and that they may play important roles in the development of B-NHL.
Although the observation of cases in which 3q27 translocation is the sole chromosome abnormality strongly suggests that the translocation can be a primary genetic defect , 3q27 translocation and/or BCL6 rearrangement frequently coexist with other B-NHL-associated translocations (Horsman et al., 1995) . These include t(8;14)(q24;q32) and its variants (Miki et al., 1994a) and t(14;18)(q32;q21) (Otsuki et al., 1995) , as well as their molecular equivalents . We and others have found that the majority of B-NHL carrying both BCL2 and BCL6 rearrangements primarily arise in nodal sites and show a follicular growth pattern (Wlodarska et al., 1995; . Retrospective examination of cases with this combination of genetic abnormalities showed an indolent clinical course even though prolonged complete clinical remission could not be achieved despite combination chemotherapy . Bastard et al. (1994) showed that BCL6 rearrangement did not in¯uence survival in patients with follicular lymphoma. Nevertheless, the clinical signi®cance of these dual rearrangements requires further investigation.
In this study, we established a new lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements. Molecular and cytogenetic analyses of these rearrangements revealed that the two genes were deregulated by t(2;18)(p11;q21) and newly identi®ed t(3;16)(q27;p11.2). Details of the molecular features of the two translocations will be presented here.
Results

Establishment of YM cell line
Lymphoma cells obtained from the ascitic¯uid of a patient with diuse large cell lymphoma of immunoblastic variant were cultured and showed de®nite proliferation in vitro. The established cell line was designated YM. The YM cells grew either as single cells or in loose clump, with a doubling time of 36 ± 48 h. The YM cells had a mature B-cell immunophenotypic pro®le; the cells were positive for CD19, CD20, HLA-DR antigens and expressed md/k monoclonal immunoglobulins on their cell surface. CD10 was negative. The YM cell line was grown for 5 years. Aliquots of the cells were frozen in liquid nitrogen and thawed cells proliferated under standard culture condition.
Rearrangement and expression of the BCL2 gene in YM cells
Genomic DNA extracted from YM cells was digested with restriction enzymes and hybridized with probes representing the three breakpoint cluster regions of BCL2, i.e. the major breakpoint cluster region (MBR), the minor cluster region (mcr) and the 5'¯anking region (5'-BCL2). The 5'-BCL2 probe detected a rearrangement, and the rearranged bands were also labeled with the Jk probe corresponding to the J region of the immunoglobulin k light chain gene (IGk (Figure 1a) suggesting that the 5'-BCL2 was fused with IGk resulting from t(2;18)(p11;q21).
To con®rm the 5'-BCL2/IGk fusion, we ampli®ed the junctional area by long distance polymerase chain reaction (LD-PCR) (Figure 2a ). Oligonucleotide primers were designed for the BCL2 exons 1 (5'-BCL2/01 primer) and 2 (5'-BCL2/02 primer) and for the constant (C) region of the IGk gene (Ck/01 primer); the primers represented the (Figure 4) . Arrows, arrowheads and asterisks represent fragments from chromosome 3, chromosome 16 and the t(3;16) junction, respectively. HindIIIdigested l DNA was used as a molecular weight marker antisense sequences of the two genes in the reverse direction, according to the head-to-head recombination. As indicated in Figure 2a , LD ± PCR generated 5.5 kb ampli®ed products with the 5'-BCL2/02 and Ck/01 primer combination, and 4.2 kb products with the 5'-BCL2/01 and Ck/01 combination. The latter PCR products were cloned into the plasmid and the restriction map encompassing the junction was constructed. Comparison with the map of the germline 5'-BCL2 and IGk as well as sequence analysis of the junctional area revealed that breakage occurred in BCL2 *560 bp upstream of the transcription initiation site of exon 1, as de®ned by Seto et al. (1988) (Figure 2b ). The BCL2 sequences were followed by the Jk4 segment (Hieter et al., 1982) of the IGk in the divergent orientation, and a sequence of 19 bp of unknown origin was inserted at the junction ( Figure  2c ). There were several base dierences between the 5'-BCL2/Jk fusion clone and their germline counterparts. It remains to be determined whether these dierences represent germline polymorphism or somatic mutation which is normally encountered at the V-(D)-J complex of IGs. The SacI site close to the transcription initiation site was not identi®ed in the fusion clone ( Figure 2b) ; sequencing analysis revealed a point mutation of GAGCTC?GACCTC. Similar molecular lesions within this particular locus have been reported in t(14;18) alleles involving MBR or mcr (SeÂ iteÂ et al., 1993a) .
Total cellular RNA was extracted from YM as well as other hematological tumor cell lines and hybridized with the MBR probe of BCL2 (Figure 3a) . The probe detected transcripts of *7.5 kb from the BCL2 gene with germline con®gurations. The YM cells showed markedly high levels of BCL2 transcripts, and the approximate size of the major mRNA species was *6.0 kb. The diuse large cell lymphoma HBL-2 cell line with ampli®cation of the BCL2 gene copies showed abundant BCL2 transcripts of normal size. The FL-218 follicular lymphoma cell line carrying a t(14;18) showed slightly faster migrating transcripts resulting from the truncation of the gene (Amakawa et al., 1991) .
Rearrangement and expression of the BCL6 gene in YM cells
Southern blot analysis of YM DNA using the F370 probe from BCL6 intron 1 revealed two rearranged bands after each restriction digestion (Figure 1b ), suggesting that rearrangement occurred within the region corresponding to the probe. The membranes were sequentially hybridized with probes representing the three IG loci, but no comigration of rearranged The 5'-BCL2 sequences were followed by the Jk4 segment in headto-head orientation. Alternating purine-pyrimidine stretches on the 5'-BCL2 were described by . Nineteen nucleotides inserted at the junction were of unknown origin (boldface letters) bands indicative of t(2;3)(p11;q27), t(3;22)(q27;q11) or t(3;14)(q27;q32) was observed (data not shown).
Northern blot analysis of RNA probed with the M55 cDNA clone of BCL6 (Figure 3b ) revealed transcripts of *3.2 kb in all cell lines tested upon longer exposure except for the diuse large cell lymphoma KIS-1. The YM cells expressed abundant BCL6 mRNA and the size of the messages ranged from 3.8 kb to 3.2 kb. High levels of BCL6 expression in FL-218 cells were reported previously .
Newly identi®ed 3q27 translocation, t(3;16)(q27;p11.2), in YM cells
To characterize further the rearrangement involving the BCL6 gene in YM cells, we cloned fragments representing the rearranged BCL6 gene by conventional genomic cloning methods (Figure 4a) . A genomic l phage library constructed from Sau3A-partially digested YM DNA was screened with the F370 probe and three positive clones were isolated. Restriction mapping of the inserts indicated that one was from the germline BCL6 and two overlapping clones included unidenti®ed sequences juxtaposed to the 5' side of the BCL6. The junctional point was 4.5 kb downstream of the BCL6 exon 1.
A human/mouse somatic cell hybrid panel was probed with the pYM-1 fragment which encompassed the junction. The newly isolated fragments were most likely from chromosomes 6, 16 and 22 (data not shown). Two overlapping phage clones corresponding to the germline sequences were isolated from a normal human genomic library (Figure 4a ). Restriction mapping of the junctional area showed results consistent with those of Southern analysis of YM DNA with the pYM-1 probe (Figure 1c ). High resolution¯uorescence in situ chromosomal hybridization (FISH) analysis using the two phage clones as probes detected a speci®c hybridization signal on subband p11.2 of chromosome 16 ( Figure 5 ). Reexamination of the karyotype of the YM cell line revealed t(3;16)(q27;p11.2) (Figure 6 ), which was misinterpreted in our previous study (Ohno et al., 1994) . These observations clearly indicated that we cloned the junctional area of the t(3;16)(q27;p11.2) translocation.
Northern blots used for the expression study of BCL2 and BCL6 were reprobed with the pYMG1.2E (Figure 4a) , which was immediately adjacent to the breakpoint on 16p11.2. As shown in Figure 3c , *280 bp transcripts were demonstrated in all cell lines tested. Fusion transcripts with those from the rearranged BCL6 in YM cells, which were expected from the structure of the t(3;16) junction, were not apparent on Northern analysis. Analysis of the 5' end of the BCL6 transcripts in YM cells by reverse transcription (RT) ± PCR and 5' rapid ampli®cation of cDNA ends (RACE) techniques showed that the majority of the BCL6 transcripts contained sequences from intron 2 (data not shown), suggesting that t(3;16) aected splicing of BCL6 transcripts (Kawamata et al., 1994) .
Nucleotide sequencing of the pYMG1.2E (accession #AB010950) as well as its¯anking regions revealed that this locus was included in the 140 kb BAC clone from 16p12 (accession #AC002303). There was no apparent open reading frame within the pYMG1.2E with signi®cant homology to proteins submitted to the data bases. Examination of the nucleotide sequences surrounding the junctional point revealed the presence of w-like octamer motifs which have been observed within IG/oncogene junctions (Wyatt et al., 1992) (Figure 4b ).
Cytogenetic analysis of YM cells using whole chromosome painting probes
To con®rm the t(2;18)(p11;q21) and t(3;16)(q27;p11.2), we analysed metaphase spreads of YM cells by whole chromosome painting probes. For t(2;18), chromosomes 2 were labeled by orange and 18 were by green. (Wyatt et al., 1992) are underlined Double-color FISH analysis revealed that the two acrocentric marker chromosomes, M3 and M5 in Figure 6 , were the der(18)t(2;18) and der(2)t(2;18), respectively ( Figure 7a ). Small chromosome 18
Figure 6 G-banded karyotype of the YM cell line. Partial karyotype showing t(3;16)(q27;p11.2) is represented in the inset. Arrows indicate the breakpoints, 3q27 on the der(3) and 16p11.2 on the der (16). The representative karyotype is: 46, X,+X, -Y, -2, -2, -4, -7, -8, -18, add(1)(p11), t(3;16)(q27;p11.2), add(13)(q22), der(14)dir ins(14;?)(q11;?), add(17)(p11), add(21)(p11), +M1, +M2, +M3, +M4,+M5, +M6 Figure 7 Chromosome painting of YM metaphase cells showing the t(2;18)(p11;q21) (a) and t(3;16)(q27;p11.2) (b). Chromosomes 2 and 3 were labeled orange and chromosomes 16 and 18 were labeled green. Relevant chromosomes involved in the two translocations are indicated. The der(18)t(2;18) had additional materials of unknown origin at the telomeric end. Other copies of chromosome 2 were rearranged. Translocated materials of the der(16)t(3;16) were not visualized segments were inserted within the chromosome 2 materials of the der(18), and the origin of additional materials of its telomeric end remained to be determined. For t(3;16), chromosomes 3 and 16 were labeled by orange and green, respectively. As shown in Figure 7b FISH analysis clearly identi®ed the der(3)t(3;16) chromosome. Materials of chromosome 3 translocated to the der(16)t(3;16) seemed to be too small to be visualized in this study.
Discussion
Here, we described the establishment of a new B-cell lymphoma cell line, YM. Molecular and cytogenetic studies clearly showed that YM cells carried two independent molecular lesions leading to deregulated overexpression of both BCL2 and BCL6 genes. A similar combination of BCL2 and BCL6 abnormalities has been described previously in other B-cell tumor cell lines (Dallery et al., 1995; GalieÁ gue-Zouitina et al., 1996) , although the signi®cance of their dual rearrangements has not been addressed.
The BCL2 gene is composed of three exons and two potential promoter regions have been identi®ed (Seto et al., 1988) . The P1 promoter is associated with exon 1 and is GC-rich with multiple SP1 sites. In contrast, P2 is located 5' to the open reading frame in exon 2, and has a classic TATA and CAAT-box and an SV40 decamer/IG octamer motif.
In established B-cell lines, the former promoter is used predominantly, while use of the latter is minimal (Seto et al., 1988) . It is of special interest that reported breakpoints of the 5'-BCL2 are clustered within a limited region immediately 5' to the P1 promoter. SeÂ iteÂ et al. (1993b) proposed use of the term vcr (variant cluster region) for this particular region since 5'-BCL2 is frequently linked to the IG light chain genes (IGL) resulting from t(2;18)(p11;q21) and t(18;22)(q21;q11). The details of the mechanism of deregulated overexpression of the BCL2 gene which is linked to the IGs in divergent orientation are not fully understood. Since YM cells carrying t(2;18) had smaller-sized BCL2 messages, it is possible that the downstream P2 promoter is activated under the in¯uence of the juxtaposed IGk gene. In common with the t(14;18) translocation, t(2;18) does not interrupt the protein coding region, producing the 25-Kd Bcl-2 protein.
An earlier study emphasized preferential linkage of 5'-BCL2/IGL fusions with chronic lymphocytic leukemia . However, we and others have demonstrated that the 5'-BCL2 is the third breakpoint cluster of translocations involving not only IGL but also the IG heavy chain gene (IGH) as a partner, and that the translocations are observed in signi®cant numbers of cases with B-NHL (Yabumoto et al., 1996) . To detect the 5'-BCL2/IGH, 5'-BCL2/IGk and 5'-BCL2/IGl fusion sequences, we have developed an LD ± PCR technique which is capable of amplifying up to 30 kb of genomic DNA (Akasaka et al., , 1998 . Primers were designed for the BCL2 exons 1 and 2, and for the Em enhancer of IGH as well as for the Ck and Cl constant regions, according to the orientation of the junctions. LD ± PCR using appropriate primer pairs is theoretically capable of amplifying these three junctions. However, as described in the Materials and methods section, optimization of the reaction components and conditions was necessary for ecient ampli®cation of junctional sequences containing the GC-rich P1 promoter area. LD ± PCR analysis of translocations involving the 5'-BCL2 from large numbers of clinical materials is currently in progress in our laboratory.
The BCL6 gene is translocated not only to the three IGs but also to many previously uncharacterized chromosomal loci, and several genes have been identi®ed in the vicinity of breakpoints on partner chromosomes (Dallery et al., 1995; GalieÁ gue-Zouitina et al., 1996; Akasaka et al., 1997) . Molecular studies have consistently shown that breakage occurs immediately 3' of BCL6 exon 1 and the 5' untranslated region of the BCL6 is substituted by many types of regulatory sequences on each partner chromosomal locus (Ye et al., 1995) . Since the coding region of BCL6 itself is not aected, the translocated allele obviously encodes the wild-type Bcl-6 protein.
However, the patterns of regulation of each regulatory sequence leading to the deregulated BCL6 expression have not yet been completely characterized. BOB1/OBF1 gene isolated from t(3;11)(q27; q23.1) is selectively expressed in B-cell lines (GalieÁ gue- Zouitina et al., 1996) . In contrast, we showed that t(3;6)(q27;p21.3) involves an H4 histone gene which is ubiquitously expressed in many cell types (Akasaka et al., 1997) . We showed here a new reciprocal translocation, t(3;16)(q27;p11.2), and found transcriptional activity on 16p11.2 immediately adjacent to the breakpoint. Although it remains to be determined whether the transcript represents a gene within this locus, the expression was uniformly observed in many types of hematologic tumor cells. Thus, it is conceivable that t(3;16) results in alteration of the pattern of BCL6 expression which is normally restricted to germinal center B-cells (Onizuka et al., 1995) .
Experiments in transgenic mice have shown that translocation involving BCL2 alone is not sucient to cause cancer, i.e. additional events are necessary for malignant transformation to occur (Korsmeyer, 1992) . When the BCL2 transgene is expressed in B lymphocytes, the mice develop follicular hyperplasia. In some animals after a long period of latency, this progresses to high-grade monoclonal lymphoma and a common second hit is translocation of the MYC oncogene (McDonnell et al., 1989; McDonnell and Korsmeyer, 1991; Marin et al., 1995) . We previously described the molecular features of lymphoma cells carrying both BCL2 and BCL6 rearrangements, and suggested that t(14;18) translocation occurs ®rst in the pre-B cell stage of B-cell development, and BCL6 rearrangement subsequently occurs at a later stage where VDJ assembly of the IGH gene has been completed . Thus, BCL6 rearrangement is potentially another second hit in t(14;18)-bearing cells ultimately leading to lymphomagenesis. In YM cells, t(3;16) which may have been mediated by IG recombination machinery-unrelated mechanism probably occurred secondarily in t(2;18)-carrying B-cells. Since BCL6 seems to function in preventing cell death of germinal center B-cells (Chang et al., 1996) , it is possible that deregulated expression of BCL6 potentiates the anti-apoptotic activity of BCL2. The cell line, YM, therefore, provides a useful model for sequential activation of BCL2 and BCL6, and for studying whether these two genes exhibit synergistic eects in the development and progression of B-NHL.
Materials and methods
Case report
The clinical features of the patient were represented in our previous papers (Ohno et al., 1994; Muramatsu et al., 1996) . Brie¯y, the patient was a 61-year-old man with stage III of NHL. Biopsy of the lymph node disclosed diuse large Bcell lymphoma of immunoblastic variant. The lymphoma was refractory to standard chemotherapy and the patient died of widespread dissemination of the disease 13 months after the initial presentation.
Cell lines
Hematological tumor cell lines used for hybridization studies as controls were as follows: KIS-1, B-cell diuse large cell lymphoma cell line with t(9;14)(p13;q32); K562, chronic myelocytic leukemia cell line; KM-H2, Hodgkin's disease cell line; DL-4, Burkitt's lymphoma/leukemia cell line with t(8;14)(q24;q32) HBL-2, B-cell diuse large cell lymphoma cell line with t(11;14)(q13;q32) and ampli®cation of the BCL2 gene; and FL-18, follicular lymphoma cell line with t(14;18)(q32;q21). These cell lines were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum under the standard culture conditions.
Immunophenotyping
Cell-surface markers were examined by binding of monoclonal antibodies as detected by indirect immunofluorescence analysis using¯ow cytometry. Surface immunoglobulins were determined by direct immunouorescence analysis using anti-human immunoglobulin antibodies.
Southern and Northern blot hybridization and DNA probes
Genomic DNA was digested with restriction enzymes, electrophoresed through 0.8% agarose gels, and transferred onto nylon membrane ®lters (GeneScreen Plus, NEN Research Products, Boston, MA). Total cellular RNA was prepared using an RNeasy TM Total RNA Kit (QIAGEN, Hilden, Germany), electrophoresed on 1.0% agarose gels containing 0.66 M formaldehyde and transferred onto membranes. The membranes were hybridized with probes labeled with 32 P-dCTP (Amersham) using a random primer labeling system (Amersham). Hybridization and washing conditions were as recommended by the manufacturer.
DNA probes used in this study were as follows: pB16 probe (Tsujimito et al., 1987) was a cDNA fragment corresponding to the second exon of BCL2 and was used to detect rearrangements within the 5'-BCL2; probe b (Tsujimoto et al., 1985) and pFL-2 (Cleary et al., 1986) recognized the MBR and the mcr of BCL2, respectively; F370 probe was within the ®rst intron of BCL6; M55 probe (Kerckaert et al., 1993) was a cDNA clone for the BCL6; and Jk probe (Hieter et al., 1982) corresponded to the J region of IGk.
Molecular cloning and nucleotide sequencing
Genomic DNA was partially digested with Sau3A, and ligated into the BamHI site of the lDASHII bacteriophage vector (Stratagene, La Jolla, CA). The ligated DNA was packaged in vitro with the Gigapack Gold system (Stratagene). Approximately 1610 6 phage clones of the library were screened by plaque hybridization. An EMBL3-normal human genomic DNA library was provided by the Japanese Cancer Research Resources Bank (JCRB, Tokyo, Japan). DNA from the isolated phage clones was puri®ed (QIAGEN lambda kit; QIAGEN) and DNA fragments of interest were subcloned into pBluescript II SK + (Stratagene) for further analyses. DNA sequences were determined by the dideoxy chain termination method using T7 DNA polymerase (Pharmacia, Piscataway, NJ) and [
35 S]dATP (Amersham).
Polymerase chain reaction (PCR) and cloning the PCR product
Oligonucleotide primers were designed to be complementary to BCL2 exon 1 (5'-BCL2/01 primer, 5'-GTGTGGTG-CGGCGAGGGGTGGGGAGAAGGAGGTG-3'), exon 2 (5'-BCL2/02 primer, 5'-CCCACATCTCCCGCATCCCAC-TCGTAGCCCCTCTG-3'), and to the constant region (C) of the IGk gene (Ck/01 primer, 5'-GCGTCAGGGTG-CTGCTGAGGCTGTAGGTGCTGTCC-3') ( Figure 5a and b). PCR ampli®cation was performed in an automated thermal cycler (DNA PCR Thermal Cycler 480, PerkinElmer, Norwalk, CT) . Each reaction mixture (50 mL) contained 100 ng of genomic DNA, reaction buer, dNTP solution including a mixture of dGTP:7-deaza dGTP (3 : 1) (Boehringer Mannheim, Indianapolis, IN) for GC-rich sequences, 20 pmol of each primer, and 2.5 U LA Taq DNA polymerase (Takara Shuzo, Kyoto, Japan). To minimize mis-priming,`hot start' (HotStart; Molecular Bio-Products, San Diego, CA) as well as touchdown' (Don et al., 1991) PCR modi®cations were adopted. The PCR protocol was as follows: denaturation at 948C for 2 min; ®ve cycles of denaturation at 988C for 20 s and primer annealing and DNA extension at 728C for 20 min; ®ve cycles of denaturation at 988C for 20 s and annealing and extension at 708C for 20 min; four cycles of denaturation at 988C for 20 s and annealing and extension at 688C for 20 min; 16 cycles of denaturation at 988C for 20 s and annealing and extension at 688C for 20 min with 15 s of auto-segment extension; further extension at 728C for 10 min; and rapid cooling to 48C. PCR products with Aoverhangs were ligated into a plasmid vector with 3' Toverhangs at the cloning site (TA Cloning; Invitrogen, San Diego, CA). Transformation and extraction of DNA were performed by established methods.
Analysis of the 5' ends of BCL6 transcripts by RT ± PCR and 5'-RACE were performed according to GalieÁ gueZouitina et al. (1996) and using a Marathon TM cDNA Ampli®cation Kit (Clontech, Palo Alto, CA).
Somatic cell hybrid panel
A panel of DNAs from nine well-characterized human/ mouse hybrids was provided by the JCRB. The DNAs were digested with appropriate restriction enzymes and hybridized with probes isolated.
High-resolution direct R-banding FISH
Pro-metaphase chromosome preparations were obtained from peripheral lymphocyte cultures of healthy donors (Takahashi et al., 1992; Akasaka et al., 1997) . The chromosome slides were stained with Hoechst 33258 and exposed to black light for 5 min at 758C. Bacteriophage DNA used as a probe was labeled with biotin-16-dUTP (Boehringer Mannheim) by nick translation. Hybridization solution consisted of bovine serum albumin (20 mg/ml; Boehringer), 106SSC and 50% dextran sulfate (1 : 2 : 2). The solution, with an equal volume of a mixture of probe DNA and Cot-1 DNA (BRL, Gaithersburg, MD) denatured in formamide, was pipetted onto the denatured chromosomes. The slides were incubated in a humid chamber at 378C for 15 ± 18 h. Hybridization signals were ampli®ed with goat anti-biotin antibody and¯uorescein-conjugated anti-goat IgG. The metaphase chromosomes were counterstained with propidium iodide. Hybridization signals were detected on the chromosomes visualized by direct Rbanding under¯uorescence microscopy (Nihon Kogaku, Tokyo, Japan).
Cytogenetic analysis
The cells were cultured with 0.001 mg/ml Colcemid for 48 h and 0.005 mg/ml ethidium bromide was added 24 h before harvest. After harvesting, the cells were treated with hypotonic solution for 20 min and ®xed with methanol:acetic acid (3 : 1). Metaphases spreads were banded with trypsin-Giemsa stain.
Chromosome painting
Whole chromosome painting probes directly labeled bȳ uorophores (SpectrumGreen and SpectrumOrange) were purchased from Vysis, Inc. (Downers Grove, IL). Hybridization and washing conditions were those recommended by the manufacturer.
